Volume | 0 |
|
|||||
Actualités | - | ||||||
Maximum Haut | Bas Haut |
||||||
Minimum Bas |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Cyteir Therapeutics Inc | CYT | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
3,02 |
Transactions Totales | Volume échangé | Volume en moyenne | Sur 52 semaines |
---|---|---|---|
0 | 0 | - | 1,67 - 3,19 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
- | 0 | US$ 3,02 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
US$ 108,71M | - | - | - | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Cyteir Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
07/3/2024 | 22:31 | Edgar (US Regulatory) | Form 8-K - Current report |
07/3/2024 | 22:30 | Business Wire | Cyteir Announces Timeline for Voluntarily Delisting from.. |
06/3/2024 | 00:11 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
15/2/2024 | 01:36 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
14/2/2024 | 01:14 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
27/12/2023 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report |
14/12/2023 | 22:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
07/12/2023 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
05/12/2023 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
22/11/2023 | 19:47 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
17/11/2023 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
06/11/2023 | 22:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Forum Action Cyteir Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Cyteir Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 mois | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
3 mois | 3,15 | 3,15 | 2,99 | 3,04 | 441 918 | -0,13 | -4,13% |
6 mois | 3,07 | 3,19 | 2,99 | 3,07 | 134 326 | -0,05 | -1,63% |
1 an | 2,29 | 3,19 | 1,67 | 2,82 | 188 631 | 0,73 | 31,88% |
3 ans | 16,50 | 23,10 | 1,13 | 5,53 | 135 353 | -13,48 | -81,70% |
5 ans | 16,50 | 23,10 | 1,13 | 5,53 | 135 353 | -13,48 | -81,70% |